Brittle and splitting nails could be a sign you have been exposed too often to water, harsh detergents, and nail polish ...

San Francisco Restaurant Closes After Telling Influencer She Wasn’t Famous Enough For Collab Authors of controversial 2010 ...

GSK has signed a $500 million upfront licensing deal with Jiangsu Hengrui to secure global rights to its COPD drug HRS‑9821 ...

China NMPA accepts for review Bayer’s NDA for sevabertinib to treat adult patients with advanced non-small cell lung cancer NSCLC: Berlin Tuesday, July 29, 2025, 13:00 Hrs [IST] ...

Real-world data support the effectiveness of combining platinum-based chemotherapy with PD-1 inhibitors for recurrent limited ...

Your sleep tracker might be more honest than you are. A massive study reveals poor sleep rhythm—not sleep duration—is what ...

Arizona woman's life is transformed after a double lung transplant allows her to breathe easier and sing again.

Ayodeji Adegunsoye, MD, PhD, MSc, highlights how the underrepresentation of minority populations in pulmonary fibrosis genetic studies hinders accurate disease risk prediction and broader clinical ...

One global clinical trial testing astegolimab for moderate to severe COPD hit its main goal, but another did not, Genentech ...

Britain's GSK and China's Jiangsu Hengrui Pharmaceuticals have agreed on a $500 million deal to develop up to a dozen new ...

The star of GSK’s Hengrui partnership is the COPD candidate HRS-9821, which will complement the pharma’s respiratory pipeline ...

Fisher, who leads Eddie Fisher Wealth Strategies of Raymond James, will help drive the Lung Association’s nationwide efforts to save lives by improving lung health and preventing lung disease.